DBV Technologies SA - American (DBVT) Price & Analysis

Compare

411 Followers

DBVT Stock Chart & Stats

Day’s Range― - ―

52-Week Range$2.20 - $12.78

Previous CloseN/A

Volume52.91K

Average Volume (3M)32.26K

Market Cap

$259.11M

Enterprise Value$121.25M

Total Cash (Recent Filing)$103.21M

Total Debt (Recent Filing)$14.59M

Price to Earnings (P/E)―

Beta0.15

Next Earnings

Oct 29, 2025

EPS Estimate

-0.32

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.31

Shares Outstanding27,395,031

10 Day Avg. Volume25,488

30 Day Avg. Volume32,258

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.47

Enterprise Value/Revenue76.60

Enterprise Value/Gross Profit-16.14

Enterprise Value/Ebitda-1.05

Forecast

1Y Price Target

$18.67

Price Target Upside89.16% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say

Clinical TrialsThe VITESSE trial in peanut-allergic children represents the last major clinical risk for the Viaskin Peanut program and is fully enrolled with a design informed by prior studies.

Market ExpansionViaskin Peanut has the potential to dramatically expand the market of children who undergo treatment for peanut allergies.

Regulatory ApprovalFDA has formalized the Accelerated Approval pathway for the Viaskin Peanut patch, which could streamline the regulatory process.

Bears Say

CompetitionOmalizumab biosimilars are expected to become widely available, which may reduce constraints on coverage/reimbursement of a branded agent.

Financial PositionDBV's current cash balance of $103.2M is expected to fund operations.

DBV Technologies SA - American News

DBV Technologies Launches $150M ATM Equity Offering

An announcement from DBV Technologies SA – American ( ($DBVT) ) is now available. On September 5, 2025,...

10d ago

DBVT

DBV Technologies’ Viaskin Peanut Program: Strategic Advancements and Regulatory Pathways Pave the Way for Investment Opportunities

Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on DBV Technologies SA – American and keeping...

2M ago

DBVT

DBV Technologies: Advancing Viaskin Peanut Towards FDA Approval with Strong Financial Backing

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA...

2M ago

DBVT

DBV Technologies Reports Progress in Clinical Trials and Financing

DBV Technologies S.A. – American Depositary Shares ( ($DBVT) ) has released its Q2 earnings. Here is a...

2M ago

DBVT

DBV Technologies appoints James Briggs as chief human resources officer

DBV Technologies (DBVT) announced the appointment of James Briggs as its chief human resources officer, succeeding Caroline Daniere....

2M ago

DBVT

Positive Outlook for DBV Technologies SA Driven by Promising Phase 3 Trial and Market Expansion Potential for Viaskin Peanut

Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA – American (DBVT –...

3M ago

DBVT

DBV Technologies Launches COMFORT Toddlers Safety Study

DBV Technologies SA – American ( ($DBVT) ) has provided an update. On June 25, 2025, DBV Technologies...

3M ago

DBVT

DBV Technologies announces first subject screened in COMFORT Toddlers trial

DBV Technologies (DBVT) provided an update on the progress on the company’s COMFORT Toddlers supplemental safety study using...

3M ago

DBVT

DBV Technologies SA Approves Key Governance Amendments

An announcement from DBV Technologies SA – American ( ($DBVT) ) is now available. On June 11, 2025,...

3M ago

DBVT

Nvidia upgraded, Salesforce downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

4M ago

Cautious Outlook on DBV Technologies: Sell Rating Amid Commercialization and Market Risks

DBV Technologies (0QAJ) has received a new Sell rating, initiated by Goldman Sachs analyst, Rajan Sharma. Rajan Sharma...

4M ago

DBVT

DBV Technologies reinstated with a Sell at Goldman Sachs

Goldman Sachs analyst Rajan Sharma reinstated coverage of DBV Technologies (DBVT) with a Sell rating and $7.25 price...

4M ago

DBVT

DBV Technologies price target raised to $21 from $15 at Citizens JMP

Citizens JMP raised the firm’s price target on DBV Technologies (DBVT) to $21 from $15 and keeps an...

4M ago

DBVT

Buy Rating for DBV Technologies Driven by Promising Viaskin Peanut Potential and Strong Market Opportunity

Sam Slutsky, an analyst from LifeSci Capital, has initiated a new Buy rating on DBV Technologies SA –...

4M ago

DBVT

DBVT FAQ

What was DBV Technologies SA - American’s price range in the past 12 months?

DBV Technologies SA - American lowest stock price was $2.20 and its highest was $12.78 in the past 12 months.

What is DBV Technologies SA - American’s market cap?

DBV Technologies SA - American’s market cap is $259.11M.

When is DBV Technologies SA - American’s upcoming earnings report date?

DBV Technologies SA - American’s upcoming earnings report date is Oct 29, 2025 which is in 44 days.

How were DBV Technologies SA - American’s earnings last quarter?

DBV Technologies SA - American released its earnings results on Jul 29, 2025. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.18 by -$0.13.

Is DBV Technologies SA - American overvalued?

According to Wall Street analysts DBV Technologies SA - American’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does DBV Technologies SA - American pay dividends?

DBV Technologies SA - American does not currently pay dividends.

What is DBV Technologies SA - American’s EPS estimate?

DBV Technologies SA - American’s EPS estimate is -0.32.

How many shares outstanding does DBV Technologies SA - American have?

DBV Technologies SA - American has 27,395,031 shares outstanding.

What happened to DBV Technologies SA - American’s price movement after its last earnings report?

DBV Technologies SA - American reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.18. Following the earnings report the stock price went down -4.082%.

Which hedge fund is a major shareholder of DBV Technologies SA - American?

Currently, no hedge funds are holding shares in DBVT

DBV Technologies SA - American Stock Smart Score

Neutral

Fundamentals

Return on Equity

-148.73%

Trailing 12-Months

Asset Growth

25.61%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

DBV Technologies SA - American

DBV Technologies SA is a biopharmaceutical company focused on developing and commercializing innovative therapies for food allergies and immunological diseases. The company is primarily engaged in the research and development of its proprietary Viaskin technology, which aims to provide a safe and effective method for desensitizing patients to allergens through epicutaneous immunotherapy. DBV Technologies operates in the biotechnology sector, with a core emphasis on addressing unmet medical needs in allergy treatment.

DBV Technologies SA - American (DBVT) Earnings & Revenues

Historic Earnings Reports

DBVT Stock 12 Month Forecast

Average Price Target

$18.67

▲(89.16% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","7":"$7","12":"$12","17":"$17","22":"$22"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$21.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$18.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,7,12,17,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.18,10.089230769230769,10.998461538461537,11.907692307692308,12.816923076923077,13.726153846153846,14.635384615384616,15.544615384615385,16.453846153846154,17.363076923076925,18.27230769230769,19.181538461538462,20.090769230769233,{"y":21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.18,9.91,10.64,11.370000000000001,12.100000000000001,12.830000000000002,13.56,14.290000000000001,15.020000000000001,15.750000000000002,16.480000000000004,17.21,17.94,{"y":18.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.18,9.704615384615384,10.22923076923077,10.753846153846153,11.278461538461539,11.803076923076922,12.327692307692306,12.852307692307692,13.376923076923077,13.901538461538461,14.426153846153845,14.95076923076923,15.475384615384614,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.5,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.65,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.81,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.97,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.22,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.45,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.61,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.74,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.18,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >